Research News

OCRF Research Finds New Factor in Ovarian Cancer Development

  (January 30, 2014)  OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development…

Read on

1 in 5 women with ovarian cancer have a genetic predisposition

At least 20% of women with ovarian cancer have a genetic predisposition to the disease even if they don’t have a family history ovarian cancer, according to a recent study. Researchers at Washington University School of Medicine in St…

Read on

2014 Ovarian Cancer Statistics

  (January 22, 2014) Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and…

Read on

OCRFA Research Identifies Biomarker that May Predict Treatment Response

(January 13, 2014) Researchers at Case Western Reserve University, led by OCRFA grantee Analisa DiFeo, PhD have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a…

Read on

Meet OCRF’s 2014 Grant Recipients

OCRF has awarded $6.5 million in research grants to 22 scientists at leading medical institutions across the country…

Read on

New combination therapy for ovarian cancer shows positive results in Phase I clinical trials

A new combination therapy developed by researchers at the Roswell Park Cancer Institute has showed positive results in 60% of women with recurrent ovarian cancer…

Read on

OCRF Research Finds New “Chemoimmunotherapy” May Be New Treatment Option

New research funded by OCRF shows that treatment with the drug decitabine, prior to administration of chemotherapy and a cancer vaccine, yielded clinical benefit for women with recurrent ovarian cancer…

Read on

New Guidelines on Risk, Genetic Counseling & Testing for BRCA-related Cancer

(December 30, 2013)   The U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer in Women…

Read on

High Volume Hospitals and Providers Improve Survival

(December 20, 2013)  Researchers have found that for women with advanced-stage ovarian cancer, being treated at a high volume hospital with a high volume provider, leads to improved survival…

Read on

Treatment in New Study on Mice with Ovarian Cancer has Positive Results

A targeted drug delivery system developed at Rutgers University could possibly make ovarian cancer more treatable…

Read on

New OCRF Research on Ovarian Cancer Proliferation, Migration, and Response to Therapy

Research funded by Ovarian Cancer Research Fund shows that adipose derived stromal cells derived from the human omentum can promote ovarian cancer proliferation, migration, chemoresistance and radiation resistance in-vitro…

Read on

OCRF Research Sheds Light on Ovarian Cancer Origins in BRCA Mutation Carriers

A team of current and former OCRF grantees at Brigham and Women’s Hospital, Harvard Medical School and Dana-Farber Cancer Institute has developed genetically engineered mouse models of high-grade serous ovarian cancer that shed light on…

Read on